P17.70 CAN ELDERLY PATIENTS WITH GLIOBLASTOMA BENEFIT FROM CONVENTIONAL CHEMO-RADIOTHERAPY TREATMENT?

BACKGROUND: Glioblastoma (GBM) is the most life-threatening primary brain tumor, especially in elderly. Despite aggressive treatment, median survival among all GBM patients is only 12-15 months and is worse in elderly (6-9 months). The standard of care for elderly remains controversial. The purpose...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Pineda, E., Valduvieco, I., Pujol, T., Oleaga, L., Ribalta, T., Caral, L., Gonzalez, J., Boget, T., Graus, F., Verger, E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2014
Aiheet:
Poster Presentations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185770/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.399
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia